| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |